60 spine surgeons performing artificial disc replacement
Here are 60 spine surgeons who offer artificial disc replacement.
Source: beckersspine.com
Spinal Disorders News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Spinal Disorders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Spinal Disorders Today - Breaking & Trending Today
12-month data from the clinical study of OssDsign Catalyst™ published in Biomedical Journal of Scientific & Technical Research
Uppsala, January 24, 2024. OssDsign AB (publ.) today announces that the previously communicated outstanding 12-month results from the clinical study TOP FUSION have been published in the peer-reviewed journal Biomedical Journal of Scientific & Technical Research. The results show a 93 % spinal fusion rate as well as improvements in quality of life and pain following surgery with the novel nanosynthetic bone graft OssDsign Catalyst.
Source: di.se
OssDsign reports exceptional data from the clinical study TOP FUSION
Uppsala, January 9, 2024. OssDsign AB today announces that positive data from the clinical study TOP FUSION has been submitted to a peer-reviewed scientific journal. Top-line results show a 93 %...
Source: marketscreener.com
Karolinska Development's portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product
STOCKHOLM, SWEDEN, January 9, 2024. Karolinska Development AB announces that the portfolio company OssDsign reports positive data from the clinical study TOP FUSION. Top-line results show a 93%...
Source: marketscreener.com
Karolinska Development's portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product
STOCKHOLM, SWEDEN, January 9, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that the portfolio company OssDsign reports positive data from the clinical study TOP FUSION. Top-line results show a 93% spinal fusion rate at 12 months as assessed with CT by independent radiological review after surgery with the novel nanosynthetic bone graft OssDsign Catalyst. The data, that has been submitted to a peer-reviewed scientific journal, indicates that the use of OssDsign Catalyst lead
Source: yahoo.com